Calithera Biosciences (CALA) Downgraded by Zacks Investment Research to Hold

Calithera Biosciences} stock has undergone multiple analysts rating changes in the recent past.  Calithera Biosciences Downgraded by Zacks Investment Research on 10/11/2021. In a note to investors, the firm issued a new rating of Hold. The analysts previously had rating of Buy.

View More Calithera Biosciences (CALA) Downgraded by Zacks Investment Research to Hold

Factors Likely to Have Influenced Earnings Results Calithera Biosciences (NASDAQ:CALA)

Earnings results for Calithera Biosciences , Analyst Opinion on Calithera Biosciences , Earnings and Valuation of (NASDAQ:CALA), Stock market Insights & financial analysis, Best stock to invest, Investment Idea,

View More Factors Likely to Have Influenced Earnings Results Calithera Biosciences (NASDAQ:CALA)

Earnings results might Drive Its Stock Price Calithera Biosciences (NASDAQ:CALA)

Earnings results for Calithera Biosciences , Analyst Opinion on Calithera Biosciences , Earnings and Valuation of (NASDAQ:CALA), Stock market Insights & financial analysis, Best stock to invest, Investment Idea,

View More Earnings results might Drive Its Stock Price Calithera Biosciences (NASDAQ:CALA)